"Chemokine CCL11" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A CC-type chemokine that is specific for CCR3 RECEPTORS. It is a potent chemoattractant for EOSINOPHILS.
| Descriptor ID |
D054413
|
| MeSH Number(s) |
D12.644.276.374.200.110.550 D12.776.467.374.200.110.550 D23.125.300.110.550 D23.469.200.110.550 D23.529.374.200.110.550
|
| Concept/Terms |
Chemokine CCL11- Chemokine CCL11
- CCL11, Chemokine
- Small Chemokine (C-C Motif) Ligand 11
- Eotaxin-1
- Eotaxin 1
- CCL11 Chemokine
- Chemokine, CCL11
- Chemokine (C-C Motif) Ligand 11
|
Below are MeSH descriptors whose meaning is more general than "Chemokine CCL11".
Below are MeSH descriptors whose meaning is more specific than "Chemokine CCL11".
This graph shows the total number of publications written about "Chemokine CCL11" by people in this website by year, and whether "Chemokine CCL11" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2004 | 0 | 1 | 1 |
| 2007 | 0 | 1 | 1 |
| 2012 | 0 | 1 | 1 |
| 2019 | 2 | 0 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Chemokine CCL11" by people in Profiles.
-
Zinc Oxide Nanowires Exposure Induces a Distinct Inflammatory Response via CCL11-Mediated Eosinophil Recruitment. Front Immunol. 2019; 10:2604.
-
Epidermal expression of eotaxins and thymic stromal lymphopoietin in eosinophil rich dermatoses. Arch Dermatol Res. 2019 Nov; 311(9):705-710.
-
Expansion of cardiac ischemia/reperfusion injury after instillation of three forms of multi-walled carbon nanotubes. Part Fibre Toxicol. 2012 Oct 16; 9:38.
-
Innate and adaptive mediators in cystic fibrosis and allergic fungal rhinosinusitis. Am J Rhinol. 2007 Sep-Oct; 21(5):538-41.
-
Alterations in eotaxin, monocyte chemoattractant protein-4, interleukin-5, and interleukin-13 after systemic steroid treatment for nasal polyps. Otolaryngol Head Neck Surg. 2004 Nov; 131(5):585-9.